Data & Analytics
Identify, Segment, and
Target the Right HCPs
Find and reach more providers with the right data foundation.
30%
of KOLs have no recorded interactions with MSLs
53
mergers and acquisitions in 2022 alone
81 %
of pharmas have moderate to no visibility into HCP/HCO relationships
Sources: Veeva Pulse, Avalere, Veeva
Improve segmentation and targeting with connected data
Learn how one top pharma leveraged four connected data sets to develop a unified HCP target list.

“When you have clean, fast data, you can have better analytics. This is how we are driving more precision engagement.”


Elodie Privat
Sales Analytics and Operations Lead, Novartis Gene Therapies
Tips & Insights
How biopharma leaders identify
and prioritize KOLs and HCPs
HCP segmentation and targeting solutions
Prioritize the right HCPs with connected customer, patient, prescriber, and KOL data.